Identification of Host Biomarkers of Epstein-Barr Virus Latency IIb and Latency III
ABSTRACT Deciphering the molecular pathogenesis of virally induced cancers is challenging due, in part, to the heterogeneity of both viral gene expression and host gene expression. Epstein-Barr virus (EBV) is a ubiquitous herpesvirus prevalent in B-cell lymphomas of immune-suppressed individuals. EB...
Guardado en:
Autores principales: | Joshua E. Messinger, Joanne Dai, Lyla J. Stanland, Alexander M. Price, Micah A. Luftig |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ebbf8fb133d6494886f8ec8bc0926aac |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Epstein-Barr Virus-Positive Adrenal Diffuse Large B-Cell Lymphoma after Treatment for Angioimmunoblastic T-Cell Lymphoma
por: Akiko Hashimoto, et al.
Publicado: (2021) -
Convulsiones y paro cardiaco: forma inhabitual de presentación de miocarditis asociada a virus de Epstein Barr
por: Mericq G,Verónica, et al.
Publicado: (1993) -
Clinical and Therapeutic Implications of Epstein–Barr Virus in HIV-Related Lymphomas
por: Miriam Verdu-Bou, et al.
Publicado: (2021) -
Falla hepática fulminante por virus Epstein Barr: Rol de los corticoides. Caso clínico
por: VIVIANI G,PAULA, et al.
Publicado: (2013) -
MicroRNAs of Epstein-Barr Virus Attenuate T-Cell-Mediated Immune Control <italic toggle="yes">In Vivo</italic>
por: Anita Murer, et al.
Publicado: (2019)